Digital and Pharmacologic Innovations in Diabetes

by Prateek Chopra | June 15, 2026 | Cardiology Conferences | ESH 2026 Unmet Cardiometabolic Need: Address the broader cardiometabolic burden in type 2 diabetes (T2DM), where ~75% of patients have concomitant hypertension and a 2–4× elevated cardiovascular (CV) risk. Treatment goals extend beyond glycemic control to include cardiovascular and renal protection, facilitated by digital health technologies and novel pharmacotherapies. Digital […]

Digital and Pharmacologic Innovations in Diabetes Read Post »